Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of lymph node metastasis and gastric corpus cancer

Table 4 Odds ratio for gastric corpus cancer and lymph node metastasis of the LOI IGF-2

Variable	Patients with gastric corpus cancer	OR for gastric corpus cancer (95% CI)
IGF2 LOI(+)	44.4% (8/18)	8 (1.425-44.920, p = .018)
Normal imprinting	9.1% (2/22)	1
	Lymph node metastasis	OR for lymph node metastasis (95% CI)
IGF2 LOI(+)	50% (9/18)	4.5 (1.084-18.689, p = .038)
Normal imprinting	18.2% (4/22)	1

OR: odds ratio; CI: confidence interval; IGF-2: insulin growth factor 2; LOI: loss of imprinting

ISSN: 1756-9966